GlaxoSmithKline PLC/ US37733W1053 /
| 2024-06-13 9:59:55 PM | Chg. -0.02 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 41.10USD | -0.05% | 66,505 Turnover: 2.73 mill. |
-Bid Size: - | -Ask Size: - | 74.42 bill.USD | - | - |
Assets
|
2009 IFRS in mill. GBP |
2010 IFRS in mill. GBP |
2011 IFRS in mill. GBP |
2012 IFRS in mill. GBP |
2013 IFRS in mill. GBP |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 9,374 | 9,045 | 8,748 | 8,776 | 8,872 | ||||||
| Intangible Assets | 8,183 | 8,532 | 7,802 | 10,161 | 9,283 | ||||||
| Long-Term Investments | 1,417 | 1,889 | 1,150 | 1,366 | 1,526 | ||||||
| Fixed Assets | 25,292 | 26,194 | 24,913 | 27,783 | 26,859 | ||||||
| Inventories | 4,064 | 3,837 | 3,873 | 3,969 | 3,900 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 6,545 | 6,057 | 5,714 | 4,184 | 5,534 | ||||||
| Current Assets | 17,570 | 16,036 | 16,167 | 13,692 | 15,227 | ||||||
| Total Assets | 42,862 | 42,230 | 41,080 | 41,475 | 42,086 | ||||||
Liabilities
|
2009 IFRS in mill. GBP |
2010 IFRS in mill. GBP |
2011 IFRS in mill. GBP |
2012 IFRS in mill. GBP |
2013 IFRS in mill. GBP |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6,772 | 6,888 | 7,359 | 8,054 | 8,317 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 1,471 | 291 | 2,698 | 3,631 | 2,789 | ||||||
| Provisions | 2,096 | 1,754 | 6,099 | 3,770 | 3,689 | ||||||
| Liabilities | 32,120 | 32,485 | 32,253 | 34,728 | 34,274 | ||||||
| Share Capital | 1,416 | 1,418 | 1,387 | 1,349 | 1,336 | ||||||
| Total Equity | 10,005 | 8,887 | 8,032 | 5,810 | 6,997 | ||||||
| Minority Interests | 737 | 858 | 795 | 937 | 815 | ||||||
| Total liabilities equity | 42,862 | 42,230 | 41,080 | 41,475 | 42,086 | ||||||
Income Statement
|
2009 IFRS in mill. GBP |
2010 IFRS in mill. GBP |
2011 IFRS in mill. GBP |
2012 IFRS in mill. GBP |
2013 IFRS in mill. GBP |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 28,368 | 28,392 | 27,387 | 26,431 | 26,505 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 8,425 | 3,783 | 7,807 | 7,392 | 7,028 | ||||||
| Interest Income | -713 | -715 | -709 | -729 | -706 | ||||||
| Income Before Taxes | 7,891 | 3,157 | 7,698 | 6,692 | 6,647 | ||||||
| Income Taxes | 2,222 | 1,304 | 2,240 | 1,948 | 1,019 | ||||||
| Minority Interests Profit | -138 | -219 | -197 | -179 | -192 | ||||||
| Net Income | 5,531 | 1,634 | 5,261 | 4,565 | 5,436 | ||||||
Per Share
Cash Flow
|
2009 IFRS in mill. GBP |
2010 IFRS in mill. GBP |
2011 IFRS in mill. GBP |
2012 IFRS in mill. GBP |
2013 IFRS in mill. GBP |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 7,841 | 7,205 | 6,250 | 4,375 | 7,222 | ||||||
| Cash Flow from Investing Activities | -4,013 | -1,149 | -112 | -2,631 | 524 | ||||||
| Cash Flow from Financing | -2,774 | -4,908 | -6,232 | -3,351 | -6,273 | ||||||
| Decrease / Increase in Cash | 1,054 | 1,148 | -94 | -1,607 | 1,473 | ||||||
| Employees | 99,913 | 96,500 | 97,389 | 99,488 | 99,451 | ||||||
